First Tracks Biotherapeutics TRAX
$41.64 −$2.82 (-6.34%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $40.70 -2.26%
Open$43.99
Prev close$44.46
Day range$41.23 – $44.74
Volume504.4K
Market cap$1.75B
P/E (TTM)–
Dividend yield–
TRAX Stock News
Headlines matching First Tracks Biotherapeutics or the TRAX ticker, most recent first.
- CCORF Initiates First Tracks Biotherapeutics(TRAX.US) With Buy Rating, Announces Target Price $50
- H.C. Wainwright Maintains First Tracks Biotherapeutics(TRAX.US) With Buy Rating, Maintains Target Price $57
- Barclays Maintains First Tracks Biotherapeutics(TRAX.US) With Buy Rating, Maintains Target Price $65
- Wedbush Maintains First Tracks Biotherapeutics(TRAX.US) With Buy Rating, Raises Target Price to $70 Positive
- Evercore Initiates First Tracks Biotherapeutics(TRAX.US) With Buy Rating, Announces Target Price $65
- Guggenheim Initiates First Tracks Biotherapeutics(TRAX.US) With Buy Rating, Announces Target Price $100
- Piper Sandler Maintains First Tracks Biotherapeutics(TRAX.US) With Buy Rating, Maintains Target Price $95
- Analysts Offer Insights on NA Companies: Arcturus Therapeutics (ARCT), EquipmentShare.com, Inc. (EQPT) and First Tracks Biotherapeutics Inc (TRAX)
- J.P. Morgan Maintains First Tracks Biotherapeutics(TRAX.US) With Buy Rating, Raises Target Price to $65 Positive
- UBS Maintains First Tracks Biotherapeutics(TRAX.US) With Buy Rating, Maintains Target Price $65
- Analysts Offer Insights on NA Companies: Cerebras Systems, Inc. Class A (CBRS), CitroTech (CITR) and First Tracks Biotherapeutics Inc (TRAX)
- A Quick Look at Today's Ratings for First Tracks Biotherapeutics(TRAX.US), With a Forecast Between $57 to $95
- Analysts Offer Insights on NA Companies: First Tracks Biotherapeutics Inc (TRAX), BETA Technologies, Inc. Class A (BETA) and Cerebras Systems, Inc. Class A (CBRS)
- UBS Initiates First Tracks Biotherapeutics(TRAX.US) With Buy Rating, Announces Target Price $65
- Wedbush Maintains First Tracks Biotherapeutics(TRAX.US) With Buy Rating, Raises Target Price to $60 Positive
No comments yet — be the first to weigh in on TRAX.
Sign in to join the discussion.